17-8173452-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_183065.4(TMEM107):c.*751C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00562 in 762,922 control chromosomes in the GnomAD database, including 26 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0045 ( 1 hom., cov: 34)
Exomes 𝑓: 0.0059 ( 25 hom. )
Consequence
TMEM107
NM_183065.4 3_prime_UTR
NM_183065.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.74
Genes affected
TMEM107 (HGNC:28128): (transmembrane protein 107) This gene encodes a transmembrane protein and component of the primary cilia transition zone. The encoded protein regulates ciliogenesis and ciliary protein composition. Human fibroblasts expressing a mutant allele of this gene exhibit reduced numbers of cilia, altered cilia length, and impaired sonic hedgehog signaling. In human patients, different mutations in this gene cause different ciliopathies, including Meckel-Gruber syndrome and orofaciodigital syndrome. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BS2
High Homozygotes in GnomAdExome4 at 25 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM107 | NM_183065.4 | c.*751C>T | 3_prime_UTR_variant | 5/5 | ENST00000437139.7 | NP_898888.1 | ||
SNORD118 | NR_033294.2 | n.137C>T | non_coding_transcript_exon_variant | 1/1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM107 | ENST00000437139.7 | c.*751C>T | 3_prime_UTR_variant | 5/5 | 1 | NM_183065.4 | ENSP00000402732 | P1 | ||
TMEM107 | ENST00000449985.6 | c.*800C>T | 3_prime_UTR_variant | 2/2 | 1 | ENSP00000404753 | ||||
SNORD118 | ENST00000363593.1 | downstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.00455 AC: 692AN: 152154Hom.: 1 Cov.: 34
GnomAD3 genomes
AF:
AC:
692
AN:
152154
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00484 AC: 1120AN: 231386Hom.: 5 AF XY: 0.00459 AC XY: 586AN XY: 127682
GnomAD3 exomes
AF:
AC:
1120
AN:
231386
Hom.:
AF XY:
AC XY:
586
AN XY:
127682
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00588 AC: 3592AN: 610650Hom.: 25 Cov.: 0 AF XY: 0.00574 AC XY: 1915AN XY: 333762
GnomAD4 exome
AF:
AC:
3592
AN:
610650
Hom.:
Cov.:
0
AF XY:
AC XY:
1915
AN XY:
333762
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00454 AC: 692AN: 152272Hom.: 1 Cov.: 34 AF XY: 0.00443 AC XY: 330AN XY: 74452
GnomAD4 genome
AF:
AC:
692
AN:
152272
Hom.:
Cov.:
34
AF XY:
AC XY:
330
AN XY:
74452
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2024 | SNORD118: PM3:Very Strong, PM2:Supporting, PS3:Supporting - |
Leukoencephalopathy with calcifications and cysts Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Laboratory of Neurogenetics and Neuroinflammation, Institut Imagine | Apr 06, 2020 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 04, 2022 | - - |
TMEM107-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 31, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at